speb/financial-data huggingface dataset:
Financial ratios for HNST — annual report dated 2022-12-31
Total revenue: 313651000
Gross profit: 92315000
Operating income: -49780000
Net income: -49019000
Capital expenditures: 1617000
Operating cash flow: -76275000
Depreciation & amortization: 8933000
Net tangible assets: 143760000
Owner earnings: -41703000
Return on net tangible assets (%): -29.008764607679467
Buffett classification: The Gruesome
Stock price: 3.01
Shares outstanding: 110078615
Book value: 146360000
P/B ratio: 2.263846892251981
Market cap (USD): 331336631.15
Debt to equity: 0.25642251981415687
Current ratio: 2.974944951242529
Quick ratio: 1.1557565272098145
COGS to revenue (%): 70.56760539580617
R&D to revenue (%): 2.2305046054372535
SG&A to revenue (%): 43.07303340336871
Free cash flow (dilution-adjusted): -92970000
Buyback yield (%): 0
Retained earnings: -439830000
Inventory turnover: 1.9136118411951861
Receivables turnover: 7.4089620635895495
Capitalized R&D asset: 6996000
ROCI (R&D-adjusted, %): -24.517566502730755
FCF margin (%): -29.641225438465046
Rule of 40 score: -29.641225438465046
Financial ratios for HNST — annual report dated 2023-12-31
Total revenue: 344365000
Gross profit: 100532000
Operating income: -36704000
Net income: -39238000
Capital expenditures: 1838000
Operating cash flow: 19353000
Depreciation & amortization: 8997000
Net tangible assets: 120600000
Owner earnings: -32079000
Return on net tangible assets (%): -26.599502487562187
Buffett classification: The Gruesome
Stock price: 3.3
Shares outstanding: 110078615
Book value: 123139000
P/B ratio: 2.949994960979056
Market cap (USD): 363259429.5
Debt to equity: 0.2423521386400734
Current ratio: 2.782084288485276
Quick ratio: 1.4861929113031211
Interest coverage ratio: -136.4460966542751
COGS to revenue (%): 70.80655699621042
R&D to revenue (%): 1.804480710873637
SG&A to revenue (%): 38.04742061475469
Free cash flow (dilution-adjusted): 1701000
Buyback yield (%): 0
Retained earnings: -479068000
Inventory turnover: 3.3179071982582666
Receivables turnover: 7.992874384922477
Capitalized R&D asset: 10901320
ROCI (R&D-adjusted, %): -22.39446362991921
Rosenberg metric: 1.1745283018867925
FCF margin (%): 0.4939526374631569
Revenue growth (%): 9.79241258596338
Rule of 40 score: 10.286365223426536
Financial ratios for HNST — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 3.57
Shares outstanding: 110078615
Market cap (USD): 392980655.55
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for HNST — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 6.93
Shares outstanding: 110078615
Market cap (USD): 762844801.9499999
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for HNST — annual report dated 2024-12-31
Total revenue: 378340000
Gross profit: 144657000
Operating income: -6331000
Net income: -6124000
Capital expenditures: 530000
Operating cash flow: 1541000
Depreciation & amortization: 9287000
Net tangible assets: 171842000
Owner earnings: 2633000
Buffett classification: The Gruesome
Stock price: 6.93
Shares outstanding: 110078615
Book value: 174307000
P/B ratio: 4.376443871732059
Market cap (USD): 762844801.9499999
Debt to equity: 0.12471099841084982
Current ratio: 3.571908029855232
Quick ratio: 2.148174122125933
COGS to revenue (%): 61.76534334196754
R&D to revenue (%): 1.8108050959454458
SG&A to revenue (%): 38.09721414600624
Free cash flow (dilution-adjusted): -14664000
Buyback yield (%): 0
Retained earnings: -485192000
Inventory turnover: 2.7406351887035862
Receivables turnover: 8.702272518170945
Capitalized R&D asset: 13323060
ROCI (R&D-adjusted, %): -3.070801315320754
Rosenberg metric: 7.10090119085935
FCF margin (%): -3.875878839139398
Revenue growth (%): 9.865985219171518
Rule of 40 score: 5.99010638003212
Financial ratios for HNST — quarterly report dated 2025-03-31
Total revenue: 97250000
Gross profit: 37670000
Operating income: 2507000
Net income: 3254000
Capital expenditures: 62000
Operating cash flow: -2938000
Depreciation & amortization: 2357000
Net tangible assets: 177911000
Owner earnings: 5549000
Return on net tangible assets (%): 3.1189752179460517
Capex to operating income (%): 2.4730753889110493
Buffett classification: The Great
Stock price: 4.7
P/E ratio: 39.748731599569766
Shares outstanding: 110078615
Book value: 180357000
P/B ratio: 2.868585585810365
Market cap (USD): 517369490.5
Debt to equity: 0.10890622487621772
Current ratio: 3.172397474207986
Quick ratio: 1.9519315277796558
Effective tax rate (%): 1.214329083181542
COGS to revenue (%): 61.26478149100257
R&D to revenue (%): 1.9043701799485864
SG&A to revenue (%): 34.252956298200516
Free cash flow (dilution-adjusted): -5412000
Buyback yield (%): 0
Retained earnings: -481938000
Inventory turnover: 0.6600784383239902
Receivables turnover: 2.274374985383194
Capitalized R&D asset: 1852000
ROCI (R&D-adjusted, %): 1.936690493567082
FCF margin (%): -5.565038560411311
Rule of 40 score: -5.565038560411311
Financial ratios for HNST — quarterly report dated 2025-06-30
Total revenue: 93459000
Gross profit: 37752000
Operating income: 2888000
Net income: 3870000
Capital expenditures: 81000
Operating cash flow: -745000
Depreciation & amortization: 2394000
Net tangible assets: 184599000
Owner earnings: 6183000
Return on net tangible assets (%): 3.349422261225684
Capex to operating income (%): 2.804709141274238
Buffett classification: The Great
Stock price: 5.09
P/E ratio: 78.6496561412128
Shares outstanding: 110078615
Book value: 187028000
P/B ratio: 2.9958089181833736
Market cap (USD): 560300150.35
Debt to equity: 0.09360630493829801
Current ratio: 4.147977768598145
Quick ratio: 2.3635885688535057
Effective tax rate (%): 1.1241696474195195
COGS to revenue (%): 59.60581645427406
R&D to revenue (%): 2.0971763019077887
SG&A to revenue (%): 35.206882162231565
Free cash flow (dilution-adjusted): -3542000
Buyback yield (%): 0
Retained earnings: -478068000
Inventory turnover: 0.5861858512306252
Receivables turnover: 2.0701501794178885
Capitalized R&D asset: 3200840
ROCI (R&D-adjusted, %): 1.7979183951444007
Rosenberg metric: 0.04427645788336933
FCF margin (%): -3.789897174161932
Revenue growth (%): -3.8982005141388174
Rule of 40 score: -7.688097688300749
Financial ratios for HNST — quarterly report dated 2025-09-30
Total revenue: 92571000
Gross profit: 34489000
Operating income: 313000
Net income: 758000
Capital expenditures: 120000
Operating cash flow: -504000
Depreciation & amortization: 2386000
Net tangible assets: 187774000
Owner earnings: 3024000
Return on net tangible assets (%): 1.6104466007008427
Capex to operating income (%): 38.33865814696485
Buffett classification: The Good
Stock price: 3.68
P/E ratio: 51.39422775945192
Shares outstanding: 110078615
Book value: 190185000
P/B ratio: 2.1299750411441494
Market cap (USD): 405089303.2
Debt to equity: 0.08075820911218025
Current ratio: 4.817106054865955
Quick ratio: 2.7255810843937334
Effective tax rate (%): 12.672811059907835
COGS to revenue (%): 62.74319171230731
R&D to revenue (%): 1.8375085069838288
SG&A to revenue (%): 35.0811809313932
Free cash flow (dilution-adjusted): -3022000
Buyback yield (%): 0
Retained earnings: -477310000
Inventory turnover: 0.6188614109298584
Receivables turnover: 2.1402214875268766
Capitalized R&D asset: 3625360
ROCI (R&D-adjusted, %): 0.0880384123076169
Rosenberg metric: -1.6647959183673469
FCF margin (%): -3.26452128636398
Revenue growth (%): -0.9501492633133246
Rule of 40 score: -4.2146705496773045
Financial ratios for HNST — annual report dated 2025-12-31
Total revenue: 371317000
Gross profit: 123755000
Operating income: -14302000
Net income: -15686000
Capital expenditures: 1510000
Operating cash flow: 15121000
Depreciation & amortization: 9550000
Net tangible assets: 167238000
Owner earnings: -7646000
Return on net tangible assets (%): -4.571927432760496
Buffett classification: The Gruesome
Stock price: 2.58
Shares outstanding: 110078615
Book value: 169669000
P/B ratio: 1.673863974562236
Market cap (USD): 284002826.7
Debt to equity: 0.08228374069511814
Current ratio: 3.9834117160904388
Quick ratio: 2.5567602668293357
COGS to revenue (%): 66.67133473554941
R&D to revenue (%): 1.9786328123948
SG&A to revenue (%): 35.20172790365106
Free cash flow (dilution-adjusted): 3099000
Buyback yield (%): 0
Retained earnings: -500878000
Inventory turnover: 3.4146011779147876
Receivables turnover: 10.998400521311572
Capitalized R&D asset: 13987790
ROCI (R&D-adjusted, %): -7.296270640043454
Rosenberg metric: -3.050941468398774
FCF margin (%): 0.8345968539011142
Revenue growth (%): -1.8562668499233492
Rule of 40 score: -1.021669996022235
Financial ratios for HNST — quarterly report dated 2025-12-31
Total revenue: 88037000
Gross profit: 13844000
Operating income: -20010000
Net income: -23569000
Capital expenditures: 1247000
Operating cash flow: 19308000
Depreciation & amortization: 2413000
Net tangible assets: 167238000
Owner earnings: -22403000
Return on net tangible assets (%): -13.395878927038114
Buffett classification: The Gruesome
Stock price: 2.58
Shares outstanding: 110078615
Book value: 169669000
P/B ratio: 1.673863974562236
Market cap (USD): 284002826.7
Debt to equity: 0.08228374069511814
Current ratio: 3.9834117160904388
Quick ratio: 2.5567602668293357
COGS to revenue (%): 84.27479355271079
R&D to revenue (%): 2.0820791258220974
SG&A to revenue (%): 36.3722071401797
Free cash flow (dilution-adjusted): 15075000
Buyback yield (%): 0
Retained earnings: -500878000
Inventory turnover: 1.0233376091364257
Receivables turnover: 2.6076538017238824
Capitalized R&D asset: 3619470
ROCI (R&D-adjusted, %): -11.227550300407346
Rosenberg metric: -12.13697824808936
FCF margin (%): 17.123482172268478
Revenue growth (%): -4.897862181460717
Rule of 40 score: 12.225619990807761
Financial ratios for HTH — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 31.94
Shares outstanding: 58530197
Market cap (USD): 1869454492.18
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for HTH — annual report dated 2022-12-31
Total revenue: 1220735000
Net income: 119294000
Capital expenditures: 5254000
Operating cash flow: 1189448000
Depreciation & amortization: 32625000
Net tangible assets: 1657335000
Owner earnings: 146665000
Return on net tangible assets (%): 8.849448059686182
Buffett classification: The Gruesome
Stock price: 27.83
P/E ratio: 13.654461938655759
Shares outstanding: 58530197
Book value: 2063529000
P/B ratio: 0.7893736325052857
Market cap (USD): 1628895382.51
Debt to equity: 0.36273054558477247
Effective tax rate (%): 23.591691379453906
COGS to revenue (%): 0
SG&A to revenue (%): 63.37886601105072
Free cash flow (dilution-adjusted): 1179650000
Buyback yield (%): 27.155580692873897
Retained earnings: 1123636000
Receivables turnover: 1.1759829681471599
Capitalized R&D asset: 0
FCF margin (%): 96.63440468242493
Rule of 40 score: 96.63440468242493
Financial ratios for HTH — annual report dated 2023-12-31
Total revenue: 1132097000
Net income: 117979000
Capital expenditures: 4228000
Operating cash flow: 443023000
Depreciation & amortization: 19630000
Net tangible assets: 1750401000
Owner earnings: 133381000
Return on net tangible assets (%): 7.620025354190268
Buffett classification: The Gruesome
Stock price: 33.33
P/E ratio: 16.535243272192506
Shares outstanding: 58530197
Book value: 2150329000
P/B ratio: 0.9072153451913636
Market cap (USD): 1950811466.01
Debt to equity: 0.30529142284738753
Effective tax rate (%): 20.88265076884904
COGS to revenue (%): 0
SG&A to revenue (%): 59.91624392609467
Free cash flow (dilution-adjusted): 434535000
Buyback yield (%): 0.2614296711322414
Retained earnings: 1189222000
Receivables turnover: 0.7192799430216446
Capitalized R&D asset: 0
FCF margin (%): 38.38319507957357
Revenue growth (%): -7.2610353598446835
Rule of 40 score: 31.122159719728884
Financial ratios for HTH — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 30.95
Shares outstanding: 58530197
Market cap (USD): 1811509597.1499999
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for HTH — quarterly report dated 2024-12-31
Capital expenditures: 916000
Buffett classification: The Gruesome
Stock price: 27.7
Shares outstanding: 58530197
Market cap (USD): 1621286456.8999999
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for HTH — annual report dated 2024-12-31
Total revenue: 1122560000
Net income: 123210000
Capital expenditures: 515000
Operating cash flow: 273932000
Depreciation & amortization: 19948000
Net tangible assets: 1910162000
Owner earnings: 142643000
Return on net tangible assets (%): 7.467586518839764
Buffett classification: The Gruesome
Stock price: 27.7
P/E ratio: 13.158724591348104
Shares outstanding: 58530197
Book value: 2218312000
P/B ratio: 0.730864935545586
Market cap (USD): 1621286456.8999999
Debt to equity: 0.3089362542329483
Effective tax rate (%): 20.126801376922927
COGS to revenue (%): 0
SG&A to revenue (%): 61.212674600912194
Free cash flow (dilution-adjusted): 266801000
Buyback yield (%): 1.2251998969991522
Retained earnings: 1248593000
Receivables turnover: 0.7729181211898378
Capitalized R&D asset: 0
FCF margin (%): 23.767192844925884
Revenue growth (%): -0.8424189799990637
Rule of 40 score: 22.92477386492682
Financial ratios for HTH — quarterly report dated 2025-03-31
Total revenue: 318457000
Net income: 44532000
Capital expenditures: 47434000
Operating cash flow: 5837000
Depreciation & amortization: 4606000
Net tangible assets: 1918986000
Owner earnings: 1704000
Return on net tangible assets (%): 0.08879689586062639
Buffett classification: The Gruesome
Stock price: 29.62
P/E ratio: 9.73268905023354
Shares outstanding: 58530197
Book value: 2228822000
P/B ratio: 0.7778388920873897
Market cap (USD): 1733664435.14
Debt to equity: 0.24626417004139406
Effective tax rate (%): 22.749193352530963
COGS to revenue (%): 0
SG&A to revenue (%): 55.341851490154085
Free cash flow (dilution-adjusted): 5040000
Buyback yield (%): 1.9196909924100989
Retained earnings: 1262586000
Receivables turnover: 0.21961385498839028
Capitalized R&D asset: 0
FCF margin (%): 1.5826312500588777
Rule of 40 score: 1.5826312500588777
Financial ratios for HTH — quarterly report dated 2025-06-30
Total revenue: 303308000
Net income: 37889000
Capital expenditures: 20482000
Operating cash flow: -234598000
Depreciation & amortization: 4428000
Net tangible assets: 1917189000
Owner earnings: 21835000
Return on net tangible assets (%): 1.13890701438408
Buffett classification: The Gruesome
Stock price: 29.71
P/E ratio: 21.098168584098712
Shares outstanding: 58530197
Book value: 2226845000
P/B ratio: 0.7808950119429058
Market cap (USD): 1738932152.8700001
Debt to equity: 0.2499837213636333
Effective tax rate (%): 23.41324385510996
COGS to revenue (%): 0
SG&A to revenue (%): 58.162000342885776
Free cash flow (dilution-adjusted): -234558000
Buyback yield (%): 2.0078414182160556
Retained earnings: 1270286000
Receivables turnover: 0.20638420062764182
Capitalized R&D asset: 0
FCF margin (%): -77.3332717897319
Revenue growth (%): -4.75700016014721
Rule of 40 score: -82.09027194987911
Financial ratios for HTH — quarterly report dated 2025-09-30
Total revenue: 330195000
Net income: 46674000
Capital expenditures: 1093000
Operating cash flow: 272954000
Depreciation & amortization: 3697000
Net tangible assets: 1902960000
Owner earnings: 49278000
Return on net tangible assets (%): 2.589544709294993
Buffett classification: The Gruesome
Stock price: 32.89
P/E ratio: 14.911949954142298
Shares outstanding: 58530197
Book value: 2216240000
P/B ratio: 0.8686144909080245
Market cap (USD): 1925058179.33
Debt to equity: 0.22634191242825688
Effective tax rate (%): 23.237340262815977
COGS to revenue (%): 0
SG&A to revenue (%): 57.54993261557565
Free cash flow (dilution-adjusted): 270993000
Buyback yield (%): 2.8596538323407805
Retained earnings: 1276539000
Receivables turnover: 0.21737584800576693
Capitalized R&D asset: 0
FCF margin (%): 82.07059464861672
Revenue growth (%): 8.864586492937871
Rule of 40 score: 90.9351811415546
Financial ratios for HTH — annual report dated 2025-12-31
Total revenue: 1219710000
Net income: 172019000
Capital expenditures: 58077000
Operating cash flow: -38696000
Depreciation & amortization: 15710000
Net tangible assets: 1877858000
Owner earnings: 129652000
Return on net tangible assets (%): 6.9042494160900345
Buffett classification: The Gruesome
Stock price: 33.59
P/E ratio: 11.429140485818428
Shares outstanding: 58530197
Book value: 2197606000
P/B ratio: 0.8946232023529241
Market cap (USD): 1966029317.2300003
Debt to equity: 0.2289341219490664
Effective tax rate (%): 22.185530821530513
COGS to revenue (%): 0
SG&A to revenue (%): 59.902517811610956
Free cash flow (dilution-adjusted): -55530000
Buyback yield (%): 9.36059286538455
Retained earnings: 1274611000
Receivables turnover: 0.767652978635292
Capitalized R&D asset: 0
FCF margin (%): -4.552721548564823
Revenue growth (%): 8.65432582668187
Rule of 40 score: 4.101604278117047
Financial ratios for HTH — quarterly report dated 2025-12-31
Total revenue: 267750000
Net income: 42924000
Capital expenditures: 8746000
Operating cash flow: -82889000
Depreciation & amortization: 2979000
Net tangible assets: 1877858000
Owner earnings: 37157000
Return on net tangible assets (%): 1.9786906145193086
Buffett classification: The Gruesome
Stock price: 33.59
P/E ratio: 11.429140485818428
Shares outstanding: 58530197
Book value: 2197606000
P/B ratio: 0.8946232023529241
Market cap (USD): 1966029317.2300003
Debt to equity: 0.2289341219490664
Effective tax rate (%): 19.227729479507737
COGS to revenue (%): 0
SG&A to revenue (%): 70.1998132586368
Free cash flow (dilution-adjusted): -97005000
Buyback yield (%): 3.0918155424886176
Retained earnings: 1274611000
Receivables turnover: 0.16851471663723297
Capitalized R&D asset: 0
FCF margin (%): -36.2296918767507
Revenue growth (%): -18.911552264570936
Rule of 40 score: -55.141244141321636
Financial ratios for HYG.L — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.001081081081081081
Shares outstanding: 8115376
Market cap (USD): 8773.37945945946
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for HYG.L — annual report dated 2022-12-31
Total revenue: -3073493.9759036144
Net income: -3312048.1927710846
Capital expenditures: 0
Operating cash flow: -579518.0722891566
Net tangible assets: 21843373.493975904
Owner earnings: -3312048.1927710846
Return on net tangible assets (%): -15.162713734142308
Buffett classification: The Gruesome
Stock price: 0.000963855421686747
Shares outstanding: 8115376
Book value: 21843373.493975908
P/B ratio: 0.00035809712079426357
Market cap (USD): 7822.049156626506
Debt to equity: 0
Free cash flow (dilution-adjusted): -579518.0722891566
Buyback yield (%): 385.07149884367647
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for HYG.L — annual report dated 2023-12-31
Total revenue: -3062025.3164556962
Net income: -3381012.658227848
Capital expenditures: 0
Operating cash flow: -581012.6582278481
Net tangible assets: 21382278.481012657
Owner earnings: -3381012.658227848
Return on net tangible assets (%): -15.812218801799668
Buffett classification: The Gruesome
Stock price: 0.0006329113924050633
Shares outstanding: 8115376
Book value: 21382278.481012657
P/B ratio: 0.00024021359223300973
Market cap (USD): 5136.313924050633
Debt to equity: 0
Free cash flow (dilution-adjusted): -581012.6582278481
Buyback yield (%): 1872.9877703756422
Receivables turnover: -806.3333333333335
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for HYG.L — annual report dated 2024-12-31
Total revenue: -4390000
Net income: -4677500
Capital expenditures: 0
Operating cash flow: -321250
Net tangible assets: 17422500
Owner earnings: -4677500
Return on net tangible assets (%): -26.847467355431192
Buffett classification: The Gruesome
Stock price: 0.0005
Shares outstanding: 8115376
Book value: 17422500
P/B ratio: 0.00023289929688621034
Market cap (USD): 4057.688
Debt to equity: 0
Free cash flow (dilution-adjusted): -321250
Buyback yield (%): 5052.138064829035
Receivables turnover: -319.27272727272725
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for HYG.L — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 17422500
Buffett classification: The Gruesome
Stock price: 0.0005
Shares outstanding: 8115376
Book value: 17422500
P/B ratio: 0.00023289929688621034
Market cap (USD): 4057.688
Debt to equity: 0
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for JAYKAY.NS — quarterly report dated 2025-12-31
Total revenue: 6680739.668040548
Gross profit: 6569878.57858973
Operating income: 897838.9216887602
Net income: 755274.5906204745
Capital expenditures: 0
Depreciation & amortization: 441829.11885930714
Owner earnings: 1197103.7094797818
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 2.174334410159296
P/E ratio: 77.27339749333063
Shares outstanding: 130287066
Market cap (USD): 283287650.80249524
Effective tax rate (%): 22.468839336763864
Interest coverage ratio: 6.8548222486817485
COGS to revenue (%): 1.6594134026978808
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): -6.037267772732411
Rule of 40 score: -6.037267772732411
Financial ratios for KAU.AX — annual report dated 2022-06-30
Total revenue: 15724053.793103449
Gross profit: 15724053.793103449
Operating income: -2035157.9310344828
Net income: -1560577.9310344828
Capital expenditures: 4098230.3448275863
Depreciation & amortization: 4676188.9655172415
Net tangible assets: 15730913.793103449
Owner earnings: -982619.3103448278
Return on net tangible assets (%): -6.246422320206316
Buffett classification: The Gruesome
Stock price: 0.10344827586206896
Shares outstanding: 605322399
Book value: 15730913.793103447
P/B ratio: 3.9806688499363765
Market cap (USD): 62619558.51724138
Debt to equity: 0.011742133050122044
Current ratio: 2.1184635012608686
Quick ratio: 1.6656870986068981
Interest coverage ratio: -123.18329437301719
COGS to revenue (%): 0
SG&A to revenue (%): 38.1781077951382
Free cash flow (dilution-adjusted): -2085911.0344827587
Buyback yield (%): 0.4089468142523943
Retained earnings: -9703215.862068966
Inventory turnover: 0
Receivables turnover: 16.394038577967734
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -11.920200415905258
FCF margin (%): -13.265733264011326
Rule of 40 score: -13.265733264011326
Financial ratios for KAU.AX — annual report dated 2023-06-30
Total revenue: 20335639.072847683
Gross profit: 20335639.072847683
Operating income: 725941.059602649
Net income: 775905.298013245
Capital expenditures: 4853554.304635761
Depreciation & amortization: 2475296.6887417217
Net tangible assets: 16701537.748344371
Owner earnings: -1602352.3178807944
Return on net tangible assets (%): -9.594040632813204
Capex to operating income (%): 668.5879301678297
Buffett classification: The Gruesome
Stock price: 0.13245033112582782
P/E ratio: 103.33110547218077
Shares outstanding: 605322399
Book value: 16469773.509933775
P/B ratio: 4.868017895757502
Market cap (USD): 80175152.18543047
Debt to equity: 0.03592091118717258
Current ratio: 1.353283113772235
Quick ratio: 0.9145931396853813
Effective tax rate (%): 0
Interest coverage ratio: 44.63964000651571
COGS to revenue (%): 0
SG&A to revenue (%): 39.13606474653916
Free cash flow (dilution-adjusted): -2729561.5894039734
Buyback yield (%): 0.050140222879807884
Retained earnings: -8516058.94039735
Inventory turnover: 0
Receivables turnover: 17.784041351750503
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.081028389772422
FCF margin (%): -13.422551313120557
Revenue growth (%): 29.32822121078516
Rule of 40 score: 15.905669897664602
Financial ratios for KPRMILL.NS — annual report dated 2022-03-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 8.042067783199263
Shares outstanding: 341814000
Market cap (USD): 2748891357.246473
Buyback yield (%): 0
Retained earnings: 354982197.0196492
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for KPRMILL.NS — annual report dated 2023-03-31
Total revenue: 725965895.2496955
Gross profit: 230890377.58830696
Operating income: 135630937.88063338
Net income: 99159561.51035324
Capital expenditures: 3459196.102314251
Operating cash flow: 36380024.360535935
Depreciation & amortization: 21155907.429963462
Net tangible assets: 451282582.2168088
Owner earnings: 116856272.83800246
Return on net tangible assets (%): 25.89425726647288
Capex to operating income (%): 2.550447675410631
Buffett classification: The Great
Stock price: 6.923020706455542
P/E ratio: 23.864419766613437
Shares outstanding: 341814000
Book value: 451484774.66504264
P/B ratio: 5.24134042285705
Market cap (USD): 2366385399.756395
Debt to equity: 0.36369105590162654
Current ratio: 2.2473814482779435
Quick ratio: 0.8147544447462948
Effective tax rate (%): 24.909607438016526
Interest coverage ratio: 15.76791277258567
COGS to revenue (%): 68.19542362814546
SG&A to revenue (%): 2.2459053250069627
Free cash flow (dilution-adjusted): -9785627.283800244
Buyback yield (%): 0.9265481593854137
Retained earnings: 409514007.3081608
Inventory turnover: 2.1409826912339476
Receivables turnover: 9.529579176259913
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 26.062909745416583
FCF margin (%): -1.347945867406689
Rule of 40 score: -1.347945867406689
Financial ratios for KPRMILL.NS — annual report dated 2024-03-31
Total revenue: 698390694.327857
Gross profit: 227617220.29020265
Operating income: 128800815.44549707
Net income: 96576328.09689412
Capital expenditures: 1056481.5925170884
Operating cash flow: 81297517.68797217
Depreciation & amortization: 22687372.586641084
Net tangible assets: 522470320.18227607
Owner earnings: 118207219.09101811
Return on net tangible assets (%): 22.624676373918952
Capex to operating income (%): 0.8202444905825504
Buffett classification: The Great
Stock price: 9.881837811900192
P/E ratio: 34.9749320190346
Shares outstanding: 341814000
Book value: 522632210.097134
P/B ratio: 6.462958930925974
Market cap (USD): 3377750509.8368526
Debt to equity: 0.2658005658260349
Current ratio: 2.891883179678938
Quick ratio: 1.1371376995127882
Effective tax rate (%): 22.591528176933647
Interest coverage ratio: 16.549614791987675
COGS to revenue (%): 67.408325720997
SG&A to revenue (%): 2.204028929167497
Free cash flow (dilution-adjusted): 42507494.90346564
Buyback yield (%): 0
Retained earnings: 481084062.8372707
Inventory turnover: 2.060506495210602
Receivables turnover: 8.701709299545781
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 22.478454319809472
FCF margin (%): 6.086492166734205
Revenue growth (%): -3.7984154768529517
Rule of 40 score: 2.2880766898812532
Financial ratios for KPRMILL.NS — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 558848542.7615862
Buffett classification: The Gruesome
Stock price: 11.309125656951743
Shares outstanding: 341814000
Book value: 559136407.0711898
P/B ratio: 6.913549946700447
Market cap (USD): 3865617477.305303
Debt to equity: 0.08373477117508955
Current ratio: 5.149575958370096
Quick ratio: 2.963951959954625
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for KPRMILL.NS — quarterly report dated 2024-12-31
Total revenue: 171047907.68154794
Gross profit: 66452966.5462175
Operating income: 29050005.8281851
Net income: 23575008.742277652
Capital expenditures: 0
Depreciation & amortization: 6177876.2093484085
Owner earnings: 29752884.951626062
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 11.501223918871663
P/E ratio: 41.689055087762675
Shares outstanding: 341814000
Market cap (USD): 3931279352.6051984
Effective tax rate (%): 20.96213216616515
Interest coverage ratio: 26.654545454545453
COGS to revenue (%): 61.1495004838424
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for KPRMILL.NS — quarterly report dated 2025-03-31
Total revenue: 198848491.9335983
Gross profit: 71339724.10568155
Operating income: 32802197.8021978
Net income: 23912789.33832125
Capital expenditures: 0
Depreciation & amortization: 6088379.705400982
Net tangible assets: 584567453.822773
Owner earnings: 30001169.04372223
Return on net tangible assets (%): 5.132199688424302
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 10.527366087058
P/E ratio: 37.62004779922364
Shares outstanding: 341814000
Book value: 584755669.8620528
P/B ratio: 6.153683148605514
Market cap (USD): 3598401111.6816435
Debt to equity: 0.09315473810475809
Current ratio: 4.291021671826625
Quick ratio: 1.8806501547987613
Effective tax rate (%): 27.136394400313474
Interest coverage ratio: 25.43880326382593
COGS to revenue (%): 64.12357800052911
Buyback yield (%): 0
Retained earnings: 544251812.0177695
Inventory turnover: 0.583729368698221
Receivables turnover: 2.901902243453041
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.410194511715435
Revenue growth (%): 16.253098110857163
Rule of 40 score: 16.253098110857163
Financial ratios for KPRMILL.NS — annual report dated 2025-03-31
Total revenue: 717293663.7830254
Gross profit: 225740004.67617488
Operating income: 124140752.86415711
Net income: 95289922.84311433
Capital expenditures: 906008.8847322889
Operating cash flow: 163820434.88426465
Depreciation & amortization: 24300911.85410334
Net tangible assets: 584567453.822773
Owner earnings: 118684825.81248538
Return on net tangible assets (%): 20.30301636472355
Capex to operating income (%): 0.7298239005556079
Buffett classification: The Great
Stock price: 10.527366087058
P/E ratio: 37.762661615395196
Shares outstanding: 341814000
Book value: 584755669.8620528
P/B ratio: 6.153683148605514
Market cap (USD): 3598401111.6816435
Debt to equity: 0.09315473810475809
Current ratio: 4.291021671826625
Quick ratio: 1.8806501547987613
Effective tax rate (%): 23.303976363875872
Interest coverage ratio: 26.674202461693042
COGS to revenue (%): 68.52892809820511
SG&A to revenue (%): 1.8843723566714963
Free cash flow (dilution-adjusted): 144099836.33387887
Buyback yield (%): 0
Retained earnings: 544251812.0177695
Inventory turnover: 2.250310406096804
Receivables turnover: 10.467849526571696
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 20.4750188958645
FCF margin (%): 20.08937811800715
Revenue growth (%): 2.7066468108314217
Rule of 40 score: 22.796024928838573
Financial ratios for KPRMILL.NS — quarterly report dated 2025-06-30
Total revenue: 197332085.18605196
Gross profit: 64925111.16311725
Operating income: 30074888.836882755
Net income: 24888836.882752165
Capital expenditures: 0
Depreciation & amortization: 6228644.980107653
Owner earnings: 31117481.86285982
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 13.286332787268899
P/E ratio: 62.74752283865036
Shares outstanding: 341814000
Market cap (USD): 4541454555.347531
Effective tax rate (%): 23.790756001433177
Interest coverage ratio: 18.49064748201439
COGS to revenue (%): 67.0985531309298
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): -0.7625940397137738
Rule of 40 score: -0.7625940397137738
Financial ratios for KPRMILL.NS — quarterly report dated 2025-12-31
Total revenue: 156672607.7754261
Gross profit: 65516319.48312354
Operating income: 26768408.154171772
Net income: 23237161.635290187
Capital expenditures: 0
Depreciation & amortization: 6038765.73465523
Owner earnings: 29275927.369945418
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 10.468753481118414
P/E ratio: 37.425210897292835
Shares outstanding: 341814000
Market cap (USD): 3578366502.3950095
Effective tax rate (%): 20.684410646387832
Interest coverage ratio: 22.249999999999996
COGS to revenue (%): 58.182658466351455
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): -20.604595229554594
Rule of 40 score: -20.604595229554594
Financial ratios for MED.SW — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 143.07692307692307
Shares outstanding: 12446448
Market cap (USD): 1780799483.076923
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MED.SW — annual report dated 2022-12-31
Total revenue: 198721739.13043478
Gross profit: 162488043.47826087
Operating income: -2032608.6956521738
Net income: -6285869.565217391
Capital expenditures: 16547826.086956521
Operating cash flow: -4266304.347826087
Depreciation & amortization: 19686956.52173913
Net tangible assets: 182378260.86956522
Owner earnings: -3146739.130434783
Return on net tangible assets (%): -1.725391565547
Buffett classification: The Gruesome
Stock price: 89.13043478260869
Shares outstanding: 12446448
Book value: 258455434.7826087
P/B ratio: 4.292257667834418
Market cap (USD): 1109357321.7391303
Debt to equity: 0.11562417202528398
Current ratio: 3.488362090775692
Quick ratio: 1.7198299853261143
Interest coverage ratio: -2.547683923705722
COGS to revenue (%): 18.233382925655274
R&D to revenue (%): 13.855948890736446
SG&A to revenue (%): 68.93350982365553
Free cash flow (dilution-adjusted): -27082608.695652176
Buyback yield (%): 0
Retained earnings: -25055434.782608695
Inventory turnover: 0.4768750983505715
Receivables turnover: 4.57849790889284
Capitalized R&D asset: 27534782.608695652
ROCI (R&D-adjusted, %): 4.78737647433854
FCF margin (%): -13.628407648886363
Rule of 40 score: -13.628407648886363
Financial ratios for MED.SW — annual report dated 2023-12-31
Total revenue: 252388095.23809525
Gross profit: 199490476.1904762
Operating income: 9904761.904761905
Net income: 736904.7619047619
Capital expenditures: 17740476.19047619
Operating cash flow: 23785714.285714287
Depreciation & amortization: 27096428.57142857
Net tangible assets: 226554761.9047619
Owner earnings: 10092857.142857142
Return on net tangible assets (%): 4.454930480384222
Capex to operating income (%): 179.11057692307693
Buffett classification: The Gruesome
Stock price: 100
P/E ratio: 1689.0171760904686
Shares outstanding: 12446448
Book value: 303522619.04761904
P/B ratio: 4.100665722724045
Market cap (USD): 1244644800
Debt to equity: 0.10560129275687465
Current ratio: 3.0772695621899206
Quick ratio: 1.5910436069283662
Effective tax rate (%): 65.44035674470456
Interest coverage ratio: 10.04830917874396
COGS to revenue (%): 20.95884078752488
R&D to revenue (%): 12.219465486825843
SG&A to revenue (%): 62.25720026791694
Free cash flow (dilution-adjusted): -76190.47619047621
Buyback yield (%): 0
Retained earnings: -36715476.190476194
Inventory turnover: 0.6505614851905537
Receivables turnover: 5.237819942682083
Capitalized R&D asset: 49288780.53830228
ROCI (R&D-adjusted, %): 5.183169371906986
Rosenberg metric: 1.3438432849849244
FCF margin (%): -0.030187824872880964
Revenue growth (%): 27.00578021433052
Rule of 40 score: 26.97559238945764
Financial ratios for MED.SW — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 241983333.3333333
Buffett classification: The Gruesome
Stock price: 62.888888888888886
Shares outstanding: 12446448
Book value: 299606666.6666667
P/B ratio: 2.6125696535457594
Market cap (USD): 782743285.3333333
Debt to equity: 0.44789835562181524
Current ratio: 5.2127680426516125
Quick ratio: 3.66139401779764
Buyback yield (%): 0
Retained earnings: -21441111.111111112
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MED.SW — annual report dated 2024-12-31
Total revenue: 249812222.2222222
Gross profit: 198536666.66666666
Operating income: 8030000
Net income: 3920000
Capital expenditures: 7595555.555555555
Operating cash flow: 35635555.55555555
Depreciation & amortization: 24777777.777777776
Net tangible assets: 241983333.3333333
Owner earnings: 21102222.22222222
Return on net tangible assets (%): 8.720527125375945
Capex to operating income (%): 94.58973294589732
Buffett classification: The Gruesome
Stock price: 62.888888888888886
P/E ratio: 199.67940952380954
Shares outstanding: 12446448
Book value: 299606666.6666667
P/B ratio: 2.6125696535457594
Market cap (USD): 782743285.3333333
Debt to equity: 0.44789835562181524
Current ratio: 5.2127680426516125
Quick ratio: 3.66139401779764
Effective tax rate (%): -41.17647058823529
Interest coverage ratio: 1.3420612813370474
COGS to revenue (%): 20.525639257931513
R&D to revenue (%): 19.171733435335877
SG&A to revenue (%): 62.493606308738556
Free cash flow (dilution-adjusted): 22237777.77777778
Buyback yield (%): 0
Retained earnings: -21441111.111111112
Inventory turnover: 0.5830595845757315
Receivables turnover: 5.428209275936164
Capitalized R&D asset: 77642930.64182195
ROCI (R&D-adjusted, %): 3.8532975355059556
Rosenberg metric: -0.030927198332433563
FCF margin (%): 8.901797350009565
Revenue growth (%): -1.0206000459106617
Rule of 40 score: 7.881197304098903
Financial ratios for MED.SW — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: 254855000
Buffett classification: The Gruesome
Stock price: 100.99999999999999
Shares outstanding: 12446448
Book value: 326506250
P/B ratio: 3.8501292027334846
Market cap (USD): 1257091247.9999998
Debt to equity: 0.47427116632530003
Current ratio: 5.306796544605455
Quick ratio: 3.5659711783216084
Buyback yield (%): 0
Retained earnings: -31592500
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MEI — annual report dated 2022-04-30
Total revenue: 1163600000
Gross profit: 264900000
Operating income: 111700000
Net income: 102200000
Capital expenditures: 38000000
Operating cash flow: 98800000
Depreciation & amortization: 52600000
Net tangible assets: 473100000
Owner earnings: 116800000
Return on net tangible assets (%): 24.688226590572818
Capex to operating income (%): 34.01969561324978
Buffett classification: The Good
Stock price: 39.04
P/E ratio: 13.550091059099804
Shares outstanding: 35471806
Book value: 913800000
P/B ratio: 1.515451199649814
Market cap (USD): 1384819306.24
Debt to equity: 0.2531188443860801
Current ratio: 3.335100742311771
Quick ratio: 2.4946977730646873
Effective tax rate (%): 13.755274261603375
Interest coverage ratio: 31.914285714285715
COGS to revenue (%): 77.23444482640083
SG&A to revenue (%): 11.524578893090409
Free cash flow (dilution-adjusted): 49000000
Buyback yield (%): 4.657647370264323
Retained earnings: 763900000
Inventory turnover: 5.670031545741325
Receivables turnover: 4.1321022727272725
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 9.304456476468138
FCF margin (%): 4.211069095909247
Rule of 40 score: 4.211069095909247
Financial ratios for MEI — annual report dated 2023-04-30
Total revenue: 1179600000
Gross profit: 264100000
Operating income: 90400000
Net income: 77100000
Capital expenditures: 42000000
Operating cash flow: 132800000
Depreciation & amortization: 49500000
Net tangible assets: 383200000
Owner earnings: 84600000
Return on net tangible assets (%): 22.077244258872653
Capex to operating income (%): 46.46017699115044
Buffett classification: The Good
Stock price: 36.39
P/E ratio: 16.74214034163424
Shares outstanding: 35471806
Book value: 952900000
P/B ratio: 1.3546217025291216
Market cap (USD): 1290819020.34
Debt to equity: 0.3519781718963165
Current ratio: 2.914035087719298
Quick ratio: 2.21359649122807
Effective tax rate (%): 14.428412874583795
Interest coverage ratio: 33.48148148148148
COGS to revenue (%): 77.6110545947779
SG&A to revenue (%): 13.13157002373686
Free cash flow (dilution-adjusted): 79300000
Buyback yield (%): 3.726316334208534
Retained earnings: 772700000
Inventory turnover: 5.732623669380088
Receivables turnover: 3.6051344743276283
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.690844497076457
FCF margin (%): 6.722617836554765
Revenue growth (%): 1.3750429700928153
Rule of 40 score: 8.09766080664758
Financial ratios for MEI — annual report dated 2024-04-30
Total revenue: 1114500000
Gross profit: 178800000
Operating income: -6100000
Net income: -123300000
Capital expenditures: 50200000
Operating cash flow: 47500000
Depreciation & amortization: 57900000
Net tangible assets: 339400000
Owner earnings: -115600000
Return on net tangible assets (%): -34.06010606953448
Buffett classification: The Gruesome
Stock price: 11.13
Shares outstanding: 35471806
Book value: 766000000
P/B ratio: 0.5154062673368146
Market cap (USD): 394801200.78000003
Debt to equity: 0.4676240208877285
Current ratio: 2.7558340535868626
Quick ratio: 1.9511668107173725
Interest coverage ratio: -0.3652694610778443
COGS to revenue (%): 83.95693135935397
SG&A to revenue (%): 14.436967249887841
Free cash flow (dilution-adjusted): -6300000
Buyback yield (%): 3.470100894559898
Retained earnings: 612300000
Inventory turnover: 5.0252416756176155
Receivables turnover: 4.180420105026257
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.5204334101185906
FCF margin (%): -0.5652759084791386
Revenue growth (%): -5.518819938962361
Rule of 40 score: -6.0840958474415
Financial ratios for MEI — quarterly report dated 2024-10-31
Capital expenditures: 0
Depreciation & amortization: 8400000
Buffett classification: The Gruesome
Stock price: 8.15
Shares outstanding: 35471806
Market cap (USD): 289095218.90000004
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MEI — quarterly report dated 2025-01-31
Total revenue: 239900000
Gross profit: 41300000
Operating income: -2200000
Net income: -14400000
Capital expenditures: 8500000
Operating cash flow: 28100000
Depreciation & amortization: 14100000
Net tangible assets: 301200000
Owner earnings: -8800000
Return on net tangible assets (%): -2.921646746347941
Buffett classification: The Gruesome
Stock price: 10.7
Shares outstanding: 35471806
Book value: 704300000
P/B ratio: 0.5389014968053386
Market cap (USD): 379548324.2
Debt to equity: 0.504330540962658
Current ratio: 2.8411122144985104
Quick ratio: 1.7547169811320755
Interest coverage ratio: -0.4
COGS to revenue (%): 82.78449353897457
SG&A to revenue (%): 15.714881200500209
Free cash flow (dilution-adjusted): 17800000
Buyback yield (%): 0
Retained earnings: 558300000
Inventory turnover: 0.9076782449725777
Receivables turnover: 1.0700267618198038
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.1994198694706309
FCF margin (%): 7.419758232596915
Rule of 40 score: 7.419758232596915
Financial ratios for MEI — quarterly report dated 2025-04-30
Total revenue: 257100000
Gross profit: 19600000
Operating income: -23600000
Net income: -28300000
Capital expenditures: 9100000
Operating cash flow: 35400000
Depreciation & amortization: 16000000
Net tangible assets: 282200000
Owner earnings: -21400000
Return on net tangible assets (%): -7.583274273564848
Buffett classification: The Gruesome
Stock price: 6.08
Shares outstanding: 35471806
Book value: 693300000
P/B ratio: 0.31107540816385404
Market cap (USD): 215668580.48
Debt to equity: 0.4950237992211164
Current ratio: 2.400943396226415
Quick ratio: 1.5686106346483706
Interest coverage ratio: -4.290909090909091
COGS to revenue (%): 92.37650719564373
SG&A to revenue (%): 14.546868922598211
Free cash flow (dilution-adjusted): 24400000
Buyback yield (%): 0
Retained earnings: 524200000
Inventory turnover: 1.2235960844925295
Receivables turnover: 1.0489596083231334
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -2.2002610479209395
FCF margin (%): 9.490470633994555
Revenue growth (%): 7.16965402250938
Rule of 40 score: 16.660124656503935
Financial ratios for MEI — annual report dated 2025-04-30
Total revenue: 1048100000
Gross profit: 163400000
Operating income: -23900000
Net income: -62600000
Capital expenditures: 41600000
Operating cash flow: 26400000
Depreciation & amortization: 58500000
Net tangible assets: 282200000
Owner earnings: -45700000
Return on net tangible assets (%): -16.194188518781004
Buffett classification: The Gruesome
Stock price: 6.08
Shares outstanding: 35471806
Book value: 693300000
P/B ratio: 0.31107540816385404
Market cap (USD): 215668580.48
Debt to equity: 0.4950237992211164
Current ratio: 2.400943396226415
Quick ratio: 1.5686106346483706
Interest coverage ratio: -1.0863636363636364
COGS to revenue (%): 84.40988455300067
SG&A to revenue (%): 15.637820818624176
Free cash flow (dilution-adjusted): -22600000
Buyback yield (%): 0.7418790425749456
Retained earnings: 524200000
Inventory turnover: 4.557959814528593
Receivables turnover: 4.2762137902896775
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -2.2282304680216294
FCF margin (%): -2.156282797442992
Revenue growth (%): -5.957828622700763
Rule of 40 score: -8.114111420143756
Financial ratios for MEI — quarterly report dated 2025-07-31
Total revenue: 240500000
Gross profit: 43500000
Operating income: 2000000
Net income: -10300000
Capital expenditures: 5800000
Operating cash flow: 25100000
Depreciation & amortization: 14900000
Net tangible assets: 279300000
Owner earnings: -1200000
Return on net tangible assets (%): -0.4296455424274973
Capex to operating income (%): 290
Buffett classification: The Gruesome
Stock price: 6.42
Shares outstanding: 35471806
Book value: 688100000
P/B ratio: 0.33095334183984887
Market cap (USD): 227728994.52
Debt to equity: 0.5051591338468245
Current ratio: 2.5009107468123863
Quick ratio: 1.6316029143897997
Interest coverage ratio: 0.3389830508474576
COGS to revenue (%): 81.91268191268192
SG&A to revenue (%): 14.844074844074845
Free cash flow (dilution-adjusted): 16800000
Buyback yield (%): 0
Retained earnings: 511000000
Inventory turnover: 1.031953902566789
Receivables turnover: 1.086760054225034
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.1866193897545955
FCF margin (%): 6.985446985446986
Revenue growth (%): -6.456631660832361
Rule of 40 score: 0.5288153246146248
Financial ratios for MEI — quarterly report dated 2025-10-31
Total revenue: 246900000
Gross profit: 47700000
Operating income: 2900000
Net income: -9900000
Capital expenditures: 4200000
Operating cash flow: -7400000
Depreciation & amortization: 15000000
Net tangible assets: 277300000
Owner earnings: 900000
Capex to operating income (%): 144.82758620689654
Buffett classification: The Gruesome
Stock price: 6.64
Shares outstanding: 35471806
Book value: 679300000
P/B ratio: 0.34672867928750184
Market cap (USD): 235532791.83999997
Debt to equity: 0.5231856322685117
Current ratio: 2.5519301470588234
Quick ratio: 1.6778492647058822
Interest coverage ratio: 0.5087719298245614
COGS to revenue (%): 80.68043742405833
SG&A to revenue (%): 15.795868772782503
Free cash flow (dilution-adjusted): -14600000
Buyback yield (%): 0
Retained earnings: 498900000
Inventory turnover: 1.0473186119873816
Receivables turnover: 1.063765618267988
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.271078706300243
FCF margin (%): -5.913325232887809
Revenue growth (%): 2.6611226611226613
Rule of 40 score: -3.2522025717651477
Financial ratios for MEI — quarterly report dated 2026-01-31
Total revenue: 233700000
Gross profit: 38800000
Operating income: -6100000
Net income: -15900000
Capital expenditures: 5300000
Operating cash flow: 15400000
Depreciation & amortization: 14600000
Net tangible assets: 273900000
Owner earnings: -6600000
Return on net tangible assets (%): -2.4096385542168677
Buffett classification: The Gruesome
Stock price: 7.93
Shares outstanding: 35471806
Book value: 675000000
P/B ratio: 0.41672803197037034
Market cap (USD): 281291421.58
Debt to equity: 0.5394074074074074
Current ratio: 2.4106260296540363
Quick ratio: 1.5465403624382208
Interest coverage ratio: -1.1296296296296295
COGS to revenue (%): 83.39751818570818
SG&A to revenue (%): 16.730851519041508
Free cash flow (dilution-adjusted): 8400000
Buyback yield (%): 0
Retained earnings: 481000000
Inventory turnover: 0.9289799809342231
Receivables turnover: 1.0690759377859103
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.5735778091208275
FCF margin (%): 3.594351732991014
Revenue growth (%): -5.34629404617254
Rule of 40 score: -1.7519423131815257
Financial ratios for ML.PA — annual report dated 2021-12-31
Capital expenditures: 0
Depreciation & amortization: 1970454545.4545455
Buffett classification: The Gruesome
Stock price: 33.40909090909091
Shares outstanding: 713302016
Market cap (USD): 23830771898.181816
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0